Fettig L, McGinn O, Finlay Schultz J, LaBarbera D, Nordeen S, Sartorius C. Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells. Oncogene. 2017;36:6074-6084 pubmed publisher

Lourenco C, Kalkat M, Houlahan K, De Melo J, Longo J, Done S, et al. Modelling the MYC-driven normal-to-tumour switch in breast cancer. Dis Model Mech. 2019;12: pubmed publisher

Forslund O, Sugiyama N, Wu C, Ravi N, Jin Y, Swoboda S, et al. A novel human in vitro papillomavirus type 16 positive tonsil cancer cell line with high sensitivity to radiation and cisplatin. BMC Cancer. 2019;19:265 pubmed publisher

Luhtala S, Staff S, Kallioniemi A, Tanner M, Isola J. Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4-1 and NRDP1, in primary breast cancer. BMC Cancer. 2018;18:1045 pubmed publisher

Pinto M, Jacobsen B, Horwitz K. An immunohistochemical method to study breast cancer cell subpopulations and their growth regulation by hormones in three-dimensional cultures. Front Endocrinol (Lausanne). 2011;2:15 pubmed publisher

Rehman I, Cross S, Azzouzi A, Catto J, Deloulme J, Larre S, et al. S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors. Br J Cancer. 2004;91:739-44 pubmed